Recruiting × Prostatic Neoplasms × Gastrointestinal × Clear all National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
The Vanguard Study: Testing a New Way to Screen for Cancer
Phase NA Recruiting
24,000 enrolled
ADVICE
Phase 1/2 Recruiting
80 enrolled
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
CERTIS1
Phase 1/2 Recruiting
695 enrolled
OMNIRAY
Phase 1 Recruiting
421 enrolled
MOMENTUM
Recruiting
8,000 enrolled
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Phase 1 Recruiting
258 enrolled
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Phase 2 Recruiting
87 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
Phase NA Recruiting
85 enrolled
VERDI
Phase NA Recruiting
1,020 enrolled
DP-04
Recruiting
100 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
The Florida ASCENT Study
Phase NA Recruiting
100 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
EXCEED
Phase 1 Recruiting
490 enrolled
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
80 enrolled
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
216 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
ID-COMET
Phase 3 Recruiting
800 enrolled
RedSedCan
Phase NA Recruiting
172 enrolled
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 Recruiting
740 enrolled
iCaRe2
Recruiting
999,999 enrolled
ODYSSEY
Phase 4 Recruiting
2,076 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Phase NA Recruiting
80 enrolled
CAMPERR
Recruiting
7,000 enrolled
A Study of DM002 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
160 enrolled
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Phase NA Recruiting
50 enrolled
Men at High Genetic Risk for Prostate Cancer
Recruiting
500 enrolled
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Phase 1/2 Recruiting
100 enrolled
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
145 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
220 enrolled
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 Recruiting
27 enrolled
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Phase 1/2 Recruiting
27 enrolled
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Phase 1/2 Recruiting
862 enrolled
Stereotactic Magnetic Resonance Guided Radiation Therapy
Phase NA Recruiting
397 enrolled
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Phase NA Recruiting
40 enrolled
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Phase 1/2 Recruiting
126 enrolled
EXCEL
Phase NA Recruiting
740 enrolled
A Multi-center Investigation of Family Health.
Recruiting
240 enrolled
GENPROS
Recruiting
4,260 enrolled
OnPoint
Phase NA Recruiting
306 enrolled
RCT-SE
Phase NA Recruiting
400 enrolled
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Phase 1 Recruiting
429 enrolled